These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Pichia pastoris-produced mucin-type fusion proteins with multivalent O-glycan substitution as targeting molecules for mannose-specific receptors of the immune system. Gustafsson A, Sjöblom M, Strindelius L, Johansson T, Fleckenstein T, Chatzissavidou N, Lindberg L, Angström J, Rova U, Holgersson J. Glycobiology; 2011 Aug; 21(8):1071-86. PubMed ID: 21474492 [Abstract] [Full Text] [Related]
4. Mucin-type fusion proteins with blood group A or B determinants on defined O-glycan core chains produced in glycoengineered Chinese hamster ovary cells and their use as immunoaffinity matrices. Lindberg L, Liu J, Gaunitz S, Nilsson A, Johansson T, Karlsson NG, Holgersson J. Glycobiology; 2013 Jun; 23(6):720-35. PubMed ID: 23424082 [Abstract] [Full Text] [Related]
5. Characterization of natural human anti-non-gal antibodies and their effect on activation of porcine gal-deficient endothelial cells. Saethre M, Baumann BC, Fung M, Seebach JD, Mollnes TE. Transplantation; 2007 Jul 27; 84(2):244-50. PubMed ID: 17667817 [Abstract] [Full Text] [Related]
6. Shiga-like toxin binds with high avidity to multivalent O-linked blood group P1 determinants on mucin-type fusion proteins. Maria Cherian R, Gaunitz S, Nilsson A, Liu J, Karlsson NG, Holgersson J. Glycobiology; 2014 Jan 27; 24(1):26-38. PubMed ID: 24082034 [Abstract] [Full Text] [Related]
7. Recombinant MUC1 mucin with a breast cancer-like O-glycosylation produced in large amounts in Chinese-hamster ovary cells. Bäckström M, Link T, Olson FJ, Karlsson H, Graham R, Picco G, Burchell J, Taylor-Papadimitriou J, Noll T, Hansson GC. Biochem J; 2003 Dec 15; 376(Pt 3):677-86. PubMed ID: 12950230 [Abstract] [Full Text] [Related]
8. Expression of GnTIII in a recombinant anti-CD20 CHO production cell line: Expression of antibodies with altered glycoforms leads to an increase in ADCC through higher affinity for FC gamma RIII. Davies J, Jiang L, Pan LZ, LaBarre MJ, Anderson D, Reff M. Biotechnol Bioeng; 2001 Aug 20; 74(4):288-94. PubMed ID: 11410853 [Abstract] [Full Text] [Related]
9. Pilot scale expression and purification of soluble protein A tagged beta 1,6N-acetylglucosaminyltransferase in CHO cells. Zeng S, Dinter A, Eisenkrätzer D, Biselli M, Wandrey C, Berger EG. Biochem Biophys Res Commun; 1997 Aug 28; 237(3):653-8. PubMed ID: 9299421 [Abstract] [Full Text] [Related]
10. Modulation of therapeutic antibody effector functions by glycosylation engineering: influence of Golgi enzyme localization domain and co-expression of heterologous beta1, 4-N-acetylglucosaminyltransferase III and Golgi alpha-mannosidase II. Ferrara C, Brünker P, Suter T, Moser S, Püntener U, Umaña P. Biotechnol Bioeng; 2006 Apr 05; 93(5):851-61. PubMed ID: 16435400 [Abstract] [Full Text] [Related]
11. Multivalent Galalpha1,3Gal-substitution makes recombinant mucin-immunoglobulins efficient absorbers of anti-pig antibodies. Liu J, Weintraub A, Holgersson J. Xenotransplantation; 2003 Mar 05; 10(2):149-63. PubMed ID: 12588648 [Abstract] [Full Text] [Related]
12. Avian influenza H5 hemagglutinin binds with high avidity to sialic acid on different O-linked core structures on mucin-type fusion proteins. Gaunitz S, Liu J, Nilsson A, Karlsson N, Holgersson J. Glycoconj J; 2014 Feb 05; 31(2):145-59. PubMed ID: 24233973 [Abstract] [Full Text] [Related]
13. The pattern of glycosyl- and sulfotransferase activities in cancer cell lines: a predictor of individual cancer-associated distinct carbohydrate structures for the structural identification of signature glycans. Chandrasekaran EV, Xue J, Neelamegham S, Matta KL. Carbohydr Res; 2006 Jun 12; 341(8):983-94. PubMed ID: 16545347 [Abstract] [Full Text] [Related]
14. Structural analysis of alpha-Gal and new non-Gal carbohydrate epitopes from specific pathogen-free miniature pig kidney. Kim YG, Gil GC, Harvey DJ, Kim BG. Proteomics; 2008 Jul 12; 8(13):2596-610. PubMed ID: 18546155 [Abstract] [Full Text] [Related]
15. Horse cytokine/IgG fusion proteins--mammalian expression of biologically active cytokines and a system to verify antibody specificity to equine cytokines. Wagner B, Robeson J, McCracken M, Wattrang E, Antczak DF. Vet Immunol Immunopathol; 2005 May 01; 105(1-2):1-14. PubMed ID: 15797470 [Abstract] [Full Text] [Related]
16. Human xenoreactive natural antibodies against Gal alpha (1-3) pig terminal residues are not produced by CD5+ B-lymphocytes. Pitre J, Möller E, Satake M. Transplant Proc; 1996 Apr 01; 28(2):545. PubMed ID: 8623257 [No Abstract] [Full Text] [Related]
17. Post-translational modifications of recombinant P-selectin glycoprotein ligand-1 required for binding to P- and E-selectin. Li F, Wilkins PP, Crawley S, Weinstein J, Cummings RD, McEver RP. J Biol Chem; 1996 Feb 09; 271(6):3255-64. PubMed ID: 8621728 [Abstract] [Full Text] [Related]
18. The xenoantibody response and immunoglobulin gene expression profile of cynomolgus monkeys transplanted with hDAF-transgenic porcine hearts. Zahorsky-Reeves JL, Kearns-Jonker MK, Lam TT, Jackson JR, Morris RE, Starnes VA, Cramer DV. Xenotransplantation; 2007 Mar 09; 14(2):135-44. PubMed ID: 17381688 [Abstract] [Full Text] [Related]
19. Cloning and functional characterization of recombinant equine P-selectin. Xu J, Cai J, Anderson B, Wagner B, Albrecht R, Peek SF, Suresh M, Darien BJ. Vet Immunol Immunopathol; 2007 Apr 15; 116(3-4):115-30. PubMed ID: 17306378 [Abstract] [Full Text] [Related]
20. Removal of xenoreactive human anti-pig antibodies by absorption on recombinant mucin-containing glycoproteins carrying the Gal alpha1,3Gal epitope. Liu J, Qian Y, Holgersson J. Transplantation; 1997 Jun 15; 63(11):1673-82. PubMed ID: 9197365 [Abstract] [Full Text] [Related] Page: [Next] [New Search]